| Name |
Title |
|
|
Robert L. Ferris, MD, PhD
|
Executive Director, UNC Lineberger Comprehensive Cancer Center & Chief of Oncology Clinical Services, UNC Health
|
Opening Remarks
|
|
Chad Pecot, MD
|
Professor, UNC Division of Oncology
|
Closing Remarks
|
|
Josh Mendell, MD, PhD
|
Professor,?Department of Molecular Biology, Investigator, Howard Hughes Medical Institute
|
New Regulators of Coding and Noncoding RNAs in Mammals
|
|
Shobha Vasudevan, PhD
|
Senior Group Leader, Genome Institute of Singapore, A*STAR, Director of Technology and Innovation, Adj A Professor UNC Chapel Hill
|
Targeting Post-Transcriptional Mechanisms of Tumor Persistence
|
|
Li Ma, PhD
|
Department of Experimental Radiation Oncology, Division of Radiation Oncology, MD Anderson Cancer Center
|
New Target against Osteoporosis and Bone Metastasis
|
|
Sun Hur, PhD
|
Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School/ HHMI
|
Perfect Storm: Breaching of Innate and Adaptive Immunity Through LINE RNA
|
|
Daniel Dominguez, PhD
|
Assistant Professor, UNC Department of Pharmacology
|
Splicing and RBPs in Cancer
|
|
Jeremy Rich, MD, MHS, MBA
|
Deputy Director for Research & Chief Scientific Officer, UNC Lineberger Comprehensive Cancer Center
|
"Kill the Messenger: Targeting RNA in Cancer Stem Cell Therapy"
|
|
Chuan He, PhD
|
Professor of Chemistry, University of Chicago/HHMI
|
Gene Expression Regulation by snoRNAs
|
|
Grace Chen, PhD
|
Assistant Professor, Yale University School of Medicine Departments of Immunobiology and Genetics
|
"N6-Methyladenosine Modification in Cancer Immunity"
|
|
Hanzhi Luo, PhD
|
Assistant Professor, Nuclear Dynamic and Cancer Epigenetic Institute (CEI) Fox Chase Cancer Center
|
"Epitranscriptomics in Cancer Immunology"
|
|
Jason Luke, MD, FACP, FASCO
|
Chief Medical officer, Strand Therapeutics (CMO)
|
Next Generation Immunotherapy via Synthetic Biology: Cell-Type and Tunable Genetic Expression
|
|
Andrea Kasinski, PhD
|
Deputy Director, Professor in the Department of Biological Sciences, Purdue University
|
From MicroRNA Biology to Clinical Breakthroughs: Advancing MicroRNAs as Anti-cancer Agents
|
|
Kevin Weeks, PhD
|
Kenan Distinguished Professor, Chemistry, University of North Carolina at Chapel Hill
|
"Small-Molecule Targeting of the Human MYC mRNA"
|
